anti human mouse cxcl12 (R&D Systems)
Structured Review

Anti Human Mouse Cxcl12, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 133 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+human+mouse+cxcl12/pmc12454664-41-33-37?v=R%26D+Systems
Average 95 stars, based on 133 article reviews
Images
1) Product Images from "Hydrogen sulfide inhibits recruitment of monocyte-derived tumor associated macrophages in glioblastoma by downregulating CXCL12"
Article Title: Hydrogen sulfide inhibits recruitment of monocyte-derived tumor associated macrophages in glioblastoma by downregulating CXCL12
Journal: Redox Biology
doi: 10.1016/j.redox.2025.103866
Figure Legend Snippet: Histologic sections of IDH wildtype glioblastoma with low H 2 S concentrations (A, D, and G) and high H 2 S concentrations (B, E, and H) were immunostained with antibody against a TAM marker CD163 (A and B), combination of antibodies against a pan-myeloid marker Iba1 (green, D and E) and resident microglia specific marker P2RY12 (red, D and E), and antibody against chemokine CXCL12 (G and H). There was an inverse correlation between tumor H 2 S concentrations and density of CD163-positive TAMs (C; n = 10, ∗P = 0.044, Spearman), percent of Iba1-positive, P2RY12-negative, peripherally derived TAMs (F; n = 10, ∗P = 0.043, Spearman), and density of CXCL12 expressing cells (I; n = 10, ∗P = 0.0005, Spearman). Scale bar, 50 μm.
Techniques Used: Marker, Derivative Assay, Expressing
Figure Legend Snippet: (A) Wildtype mice fed a diet containing H 2 S donor SG1002 (40 mg/kg/d; n = 5) demonstrated increased plasma free H 2 S concentrations compared to those fed a control diet (n = 5; ∗∗∗∗P < 0.0001, t -test). (B) Similarly, relative plasma SSP4 fluorescence (indicating sulfane sulfur concentrations) was increased in the SG1002 group (n = 4) compared to controls (n = 4, ∗P = 0.016, t -test). (C) Kaplan-Meier curves showing overall survival for Nestin-TVA mice injected with RCAS-PDGFB and RCAS-STAT3 and fed a control (n = 25) or SG1002-containing diet (n = 25, ∗P = 0.020, log-rank test). Histologic sections of tumors from control (D, G, and J) and SG1002 groups (E, H, and K) were immunostained with an antibody against Iba1 (D and E), combination of antibodies against a pan-myeloid marker Iba1 (green, G and H) and resident microglia specific marker P2RY12 (red, G and H), and antibody against chemokine CXCL12 (J and K). SG1002 administration decreased accumulation of Iba1-positive TAMs (F, n = 4, ∗P = 0.013, t -test), relative abundance of Iba1-positive, P2RY12-negative, peripherally derived TAMs (I: n = 4, ∗∗P = 0.0018, t -test) and density of CXCL12 expressing cells (L, n = 3–4, ∗P = 0.036, t -test). Scale bar, 50 μm.
Techniques Used: Clinical Proteomics, Control, Fluorescence, Injection, Marker, Derivative Assay, Expressing
Figure Legend Snippet: (A) Transwell migration of THP-1 macrophages in response to conditioned media (CM) from T98G glioblastoma cells treated with PBS or 100 μM Na 2 S 4 , as well as serum-free media (NC) or media containing 10 % serum (PC). (B) CM from PBS treated T98G cells promoted chemotaxis of THP-1 macrophages compared to NC (∗∗P = 0.0070, ANOVA with Tukey's post hoc test), but this effect was abrogated with CM from Na 2 S 4 treated T98G cells. (∗P = 0.010, ANOVA with Tukey's post hoc test). Data are representative of 6 independent experiments per each condition. Scale bar, 50 μm. Na 2 S 4 treatment of T98G cells decreased CXCL12 transcript levels (C) and CXCL12 concentrations in CM (D) compared to PBS treatment (n = 3, ∗P = 0.010, ∗∗∗∗P < 0.0001, t -test).
Techniques Used: Migration, Chemotaxis Assay
